Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $590 - $605 million -- KPL-387 ...

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...

A multidisciplinary team of researchers at University of Cincinnati Cancer Center is conducting a clinical trial to identify ... are pursuing reconstruction. Participants also will receive ...

Background: Differences exist between European and American guideline recommendations regarding targets for low-density ...

The phase 3 clinical trial involved nearly 34,000 patients aged over 40 in rural China. People in 163 villages were provided hypertension treatment through medicines and lifestyle changes ...

In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses how advances in data and AI can help.

Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk’s Ozempic in clinical trials. For some patients, injectables ...

Good morning and welcome to the Darling Ingredients Inc conference call to discuss the company's first quarter, 2025 financial results (Operator Instructions) I would now like to turn the call over to ...

Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

Objectives: To evaluate the safety of using misoprostol for labor induction in twin pregnancies. Methodology: To address the research question regarding the safety and efficacy of misoprostol for ...

The dashboard provides real-time analytics on subject compliance, engagement, site performance, and visit adherence. Credit: © Clinical ink. All rights reserved ...